Skincare Clinic
This page summarizes the published SME benchmark for this business type, including its disclosed market basis, so advisors and operators can cite a clear starting point before a full company-specific valuation.
Business type benchmark
Last published: 15 Apr 2026fresh · 49 days old≈ 6 min readEndpoint
Model-ready data package
Pull this sector's multiples together with country market data in one response. Use JSON for agents and apps, or CSV for Excel models and deal workpapers.
/api/benchmarks/v1/context?business_type_id=skincare-clinic&locale=enClassification
86.90.5
NACE Rev. 2 primary code. National statistical labels (e.g. SBI, NACE-BEL) describe how each country maps this activity.
Markets
Benelux aggregate
Published benchmark
15 Apr 2026
Published benchmark ranges
Sign up free to see P25, median, and P75 ranges and NACE codes. No credit card.
Sign up freeHow To Use This Benchmark
Use these ranges as a market reference, not as a substitute for a full valuation. Company quality, growth, concentration, recurring revenue, margin profile, and deal context still matter.
Pair This With The Right Valuation Method
These benchmark pages work best when they feed into a fuller valuation workflow on Upswitch. Start with the market range, then choose the method that fits the company.
Upswitch Index vs Damodaran
Both are useful — they answer different questions. Pick the right reference for the work.
Upswitch Index
Private-market, SME, by business type
- Benelux-native where the row proves local evidence
- By business type, disclosed market basis, citable vintages
- Free to use — no credit card
Damodaran
Listed equities, global, by sector
- Public-market companies, annual global cuts
- Broad sector buckets, not country-resolved
- Free academic resource
Healthcare and social services
How skincare clinic actually gets valued
The multiples above are a market anchor — not the valuation. What drives the outcome are sector-typical normalisations, value drivers and risk compressors.
Normalisation checklist
What reported EBITDA almost always distorts in this sector.
- Adjust owner-clinician compensation to a market-rate associate-plus-locum baseline.
- Separate fee-for-service revenue from capitation / public-funding revenue — they value differently.
- Strip COVID-era subsidies and one-off recovery payments.
- Reflect the cost of locum or substitute coverage during transition.
- Verify regulatory-licence transferability under the proposed deal structure.
Value drivers
What typically lifts the multiple in this sector.
- Multi-clinician practice with documented patient retention per provider.
- Long-term contracts with mutuals, insurers or public payers.
- Specialised practice area with limited substitutes in catchment.
- Modern facility and equipment, no major capex due in next 3 years.
Value killers
What compresses the multiple or kills the deal.
- Solo-practitioner with personal patient relationships.
- Pending regulatory inspection or open complaint files.
- Reimbursement-rate cuts announced by the public payer.
- Practice tied to a single specialist whose succession is unclear.
Anonymised worked example
Illustrative — not a recommendation. Real valuations run through the Upswitch engine.
A multi-disciplinary clinic reports €3.2M revenue and €590k EBITDA, with the owner-physician personally generating 35% of consultations. Normalising the owner to a market-rate senior physician (€180k vs €110k drawn) and reflecting €40k locum cost during transition reduces EBITDA to €490k. A sector range of 5.0×–6.5× yields €2.45M–€3.18M, with multiple expansion supported by a 4-physician roster and stable mutual-insurer contracts; the lower bound reflects the owner-generated 35% concentration.
Frequently Asked Questions
Are these published numbers company-specific?
No. They are published market reference points for this business type in the country markets that Upswitch has evidence for. A real valuation still needs company-specific inputs and judgment.
Why do some business types show more than one metric?
Different sectors are often discussed with different market lenses. Upswitch shows the published metrics that are available for this business type.
Can I use this in a client conversation?
Yes. These pages are designed as citation-friendly starting points. For a client-ready report, use the full valuation workflow on Upswitch.
Is this database free to use?
Yes. The Upswitch Index publishes free SME valuation multiples (EV/EBITDA, EV/Revenue, and P/E) by business type. Benelux can be native-local where row evidence supports it; wider European market views are disclosed as beta, borrowed, aggregate, or compatibility coverage. Historical vintages and audit exports are on paid plans.
How does Upswitch Index compare to Damodaran?
Damodaran publishes annual global multiples for listed companies by broad sector — a gold standard for public markets. Upswitch Index publishes granular SME/private-company benchmark ranges by business type with row-level disclosure of whether evidence is native-local, borrowed, aggregate, or beta-stage. Both are useful; they answer different questions.
What is the source methodology behind these multiples?
Upswitch publishes only through row-level benchmark contracts. Evidence can include private-market observations, local filings or statistics, listed-comparable context, and macro calibration anchors, but source labels are used only when they actually contributed to the resolved benchmark. Full methodology is on the methodology page.
Related Business Types
Deeper reading
How valuation, normalisation and succession actually work
Three long-form articles on the infrastructure layer beneath European SME succession — selected for this sector.
Europe's €100B SME succession crisis
450,000 European family businesses look for a successor each year — 150,000 transactions fail. Why this is an infrastructure problem.
Read on upswitch.app →
Algorithmic transparency in valuation
A defensible valuation makes every assumption, multiple and parameter visible. From Excel black box to reproducible audit trail.
Read on upswitch.app →
Cross-border M&A in the Benelux — foreign buyers
30-45% of strategic acquirers for Belgian and Dutch SMEs sit in Germany, France or the UK. Synergy, buyer typology and what this means.
Read on upswitch.app →
Upswitch.app
Full valuation workflow — Upswitch
This database is the public benchmark layer. Upswitch is the full platform: company-specific valuations, client-ready reports, advisor workflow, and API access for teams. Free accounts work across both.